Defined sequences for glycan research

Oligosaccharide Synthesis Services

BOC Sciences supports custom oligosaccharide synthesis with specified monosaccharide sequences, glycosidic linkages, stereochemistry, branches, and terminal groups. Projects cover native glycan motifs and deliberately modified analogs for glycan recognition studies, research standards, molecular probes, and drug discovery.

  • Translate a named glycan motif into a complete finite structure.
  • Choose chemical, enzymatic, or combined assembly for the specific target.
  • Align structural evidence and purity assessment with the intended comparison.

Discuss Your Target Explore Synthesis Options

Illustrative LacNAc Gal-beta1,4-GlcNAc-R with the nonreducing end, beta1,4 linkage, and specified reducing-end format identified separately.Schematic type 2 LacNAc example: Gal-beta1,4-GlcNAc. R denotes the separately specified reducing-end format; a fixed glycoside also needs its attachment configuration. Other oligosaccharides require their own complete sequence, branches, and modifications.

Structure-first project review

Define the target and the evidence needed
01 Complete sequence and residue numbering
02 Every linkage position and configuration
03 Branch topology and terminal modifications
04 Free glycan or specified reducing-end derivative
05 Desired comparators, labels, or coupling handles
06 Quantity and acceptance criteria

Custom glycan synthesis

Oligosaccharide Synthesis by Structure and Glycan Family

Biological origin helps identify a research context, but a synthesis target needs an explicit structure. The service areas below distinguish chemical analog design from native glycan families and their defined fragments. Requests can include one structure or a related series with controlled differences in length, branching, substitution, or terminal presentation.

Develop defined glycosaminoglycan fragments with specified backbone residues, uronic acid epimers, and N- or O-substitution patterns. Chain length and total sulfo content alone do not identify the placement of groups along a GAG sequence.

  • Specify residue count and backbone identity.
  • Map each N- and O-modification by position.
  • Define both ends, counterion, and purity basis.

Prepare halogenated glycan analogs with the halogen identity, modified residue, attachment position, and local stereochemistry specified. A site-defined fluorinated analog, for example, represents a particular chemical change rather than a generic replacement for every parent glycan.

  • Identify the modified atom and retained groups.
  • Review donor, acceptor, and enzyme compatibility.
  • Plan matched parent or positional comparators.

Build oligosaccharide analogs containing a specified carbocyclic sugar unit. Replacing a ring oxygen with carbon changes the sugar skeleton and must be distinguished from forming an external C-glycosidic connection at the anomeric center.

  • Specify the carbocyclic residue structure.
  • Define neighboring bonds and stereochemistry.
  • Characterize the actual analog rather than assume native behavior.

Define mammalian glycan motifs, including selected N-glycan, O-glycan, and glycolipid headgroup structures. Core architecture, antenna composition, terminal sugars, and reducing-end format distinguish individual targets within these broad families.

  • State the glycan family and full topology.
  • Specify fucosylation or sialylation positions.
  • Separate a glycan headgroup from its conjugate.

Develop finite bacterial glycan structures from a verified sequence or repeat-unit reference. Species and serotype labels are connected to exact residues, inter-repeat junctions, branches, and native substitutions where relevant.

  • Provide the structural source and naming.
  • Define fragment boundaries and end groups.
  • Distinguish capsular, O-antigen, and other targets.

Prepare defined fragments of fungal glycan motifs, such as specified glucan or mannan sequences, for structure-focused research. Organism names alone do not establish linkage pattern or branch placement, and a fragment does not reproduce the complete organization of a fungal cell wall.

  • Specify backbone and branch linkages.
  • Identify the exact finite sequence.
  • Define substitutions and any immobilization handle.

Develop defined plant glycan fragments and selected modified series. Projects can distinguish backbone structure, branch identity, terminal residues, and positional substitutions relevant to a particular plant carbohydrate motif.

  • Identify the structural family and sequence.
  • Map branch and substitution positions.
  • Separate defined fragments from extracted mixtures.

Prepare specified human milk oligosaccharide structures and research derivatives with defined lactose-based cores, extensions, fucosylation, or sialylation as applicable. Similar compositions can encode different linkages, so the requested isomer remains an explicit part of the order.

  • Confirm the named HMO against a drawing.
  • Specify terminal linkages and reducing-end form.
  • Treat nutritional or biological validation as a separate study.

Prepare heparan sulfate oligosaccharides with specified chain lengths, GlcA/IdoA sequences, and N- and O-sulfation patterns. Each target is defined by residue-specific modification positions, both fragment ends, and the supplied ionic form.

  • Specify residue count and uronic acid configuration.
  • Map N- and O-sulfation sites along the sequence.
  • Define counterion, purity method, and structural documentation.

Develop defined capsular repeat units and finite oligosaccharide fragments for a specified bacterial species and serotype. Projects address the requested sequence, repeat junctions, branches, and native substitutions, with fragment boundaries and reducing-end functionality defined explicitly.

  • Verify species, serotype, and structural reference.
  • Specify repeat count, fragment boundaries, and substitutions.
  • Define end groups, purity requirements, and identity documentation.
Turn a glycan motif into one finite target. Identify every residue and bond: Define configuration, branch topology, and both ends. Review chemical and enzymatic options: Match selectivity and substrate tolerance to the target. Control the variable being compared: Match the spacer, label, and presentation where needed. Distinguish plausible structural alternatives: Mass, sequence, linkage, isomer, and end-group evidence.

Project schematic

Specify the complete finite sequence, every bond, branch, and end group. Biological family and residue composition guide the brief but do not substitute for a structural assignment.

Target-specific route selection

Build the Sequence Around Its Difficult Connections

The number of residues is only one contributor to synthesis complexity. Linkage selectivity, branch accessibility, protecting-group compatibility, enzyme substrate tolerance, and final purification all influence the route. A project-specific plan identifies which structural features need direct control and which possible alternatives must be distinguished analytically.

Choose the Assembly Mode for the Target

Chemical assembly offers access to designed residue analogs and protection patterns. Enzymatic steps can introduce selected native linkages when the donor and acceptor are accepted by the enzyme. Combined routes may connect these advantages, but an enzyme that acts on a native substrate cannot be assumed to accept every modified analog.

Plan Branches, Labile Groups, and Both Ends

Map the order of backbone extension, branch construction, and terminal modification. Sialic acids, sulfo groups, phosphates, or other sensitive features can influence deprotection and purification. A reducing-end linker may need to be introduced early, especially when the final product must retain a fixed attachment configuration.

Define a Comparative Series Before Synthesis

Keep the intended comparison explicit: sequence isomer, branch position, terminal sugar, length, or analog substitution. Match the spacer, immobilization chemistry, and labeling state where those are not the experimental variable. This helps prevent presentation differences from obscuring a glycan-structure comparison.

Discuss the Synthesis Route

Structure specification

Match Oligosaccharide Format to the Research Question

A probe precursor, a free glycan, and an analytical comparator can share the same carbohydrate sequence while needing different ends, quantities, and acceptance evidence. Define the intended role before selecting the delivery format.

Research objectiveMaterial format to defineUseful comparisonAcceptance focus
Compare recognition of two linkagesA matched pair differing at one defined glycosidic bondParent, linkage isomer, and handle-only control where relevantEvidence distinguishing the specified linkage and matched presentation
Develop an analytical methodA structurally characterized free or derivatized glycanRelevant isomers or neighboring lengthsIdentity, purity method, concentration or content basis, and compatibility with derivatization
Prepare a glycan probeA defined glycan with an agreed reactive end or labelUnlabeled glycan and appropriate label or surface controlsAttachment position, linker identity, and residual free label where applicable
Study substitution effectsA parent motif and site-defined modified analogsPosition-matched or unsubstituted comparatorsResidue and modification placement, not only total modification count
Assess an enzyme substrateA sequence with compatible ends and required reactive sitesStarting material and structurally defined product comparatorsActual substrate identity and suitability for the chosen assay conditions

Research standards are supplied against an agreed identity and analytical scope. Suitability for a particular regulated assay, certified reference-material status, or biological performance requires explicit evaluation beyond synthesis alone.

Structure-to-data consistency

Evidence for Sequence, Linkages, and Product Homogeneity

Oligosaccharides with equal mass can differ in residue configuration, sequence, linkage, or branching. The characterization plan should therefore identify both the expected product and the structurally relevant alternatives. Different methods contribute complementary information.

Explore Glycan Characterization

Composition

Mass and Residue-Level Information

Suitable mass spectrometry supports molecular composition and modification count, while residue analysis can provide complementary composition data. Neither measurement alone establishes the full order and configuration of every bond.

Assignment

Sequence and Linkage Evidence

NMR, informative MS/MS, suitable enzyme treatments, and comparison with characterized standards can support structural assignment. The combination depends on sample amount, complexity, and the precise distinction that must be resolved.

Uniformity

Length, Branch, and Positional Alternatives

Chromatography and orthogonal checks are chosen to assess relevant truncations, incomplete extensions, or isomers. A purity value should state its method and detection basis; unresolved isomers may require a separate targeted analysis.

Supplied form

Ends, Labels, and Ionic State

Documentation identifies the actual reducing-end derivative, protection state, label, counterion, or other agreed material feature. For conjugation inputs, the presence of a reactive handle should be supported independently of the glycan headgroup assignment.

Research and method development

Applications for Structurally Defined Oligosaccharides

Defined material makes it possible to test a specific molecular hypothesis. The synthesis project establishes the glycan and its delivery form; interpretation of recognition, stability, or biological activity remains tied to the experimental system.

Glycan Recognition and Specificity Studies

Compare lectin, antibody, receptor, or enzyme recognition across selected sequences and isomers. Maintaining equivalent linker and display conditions helps distinguish carbohydrate recognition from differences in surface density or orientation.

Research Standards and Method Development

Use characterized structures in retention, fragmentation, derivatization, and isomer-separation studies. A comparator can support an assignment only within the resolution and coverage of the analytical method used.

Glycan Probes and Conjugate Inputs

Introduce defined amine, azide, alkyne, biotin, or fluorescent functionality when compatible with the target. Free glycan supply, labeled glycan preparation, and final carrier or surface construction are separately defined deliverables.

Drug Discovery and Enzyme Research

Prepare substrate analogs, inhibitor candidates, or glycan fragments for mechanistic and medicinal chemistry research. Chemical resemblance to a native glycan does not establish binding, inhibition, cellular uptake, or therapeutic performance.

A defined research project

Oligosaccharide Synthesis from Brief to Structural Record

BOC Sciences reviews the target as a complete molecule, including its ends and the evidence needed to distinguish related structures. Sequence definition and analytical scope are settled together before route execution.

Project brief

Send the structure and specifications

Provide a drawing or unambiguous sequence, a literature reference if available, desired end groups, requested quantity, and intended use. For a series, mark the structural change between members and identify the variables that should remain matched.

Start an Inquiry

1 Verify the Target and Family

Reconcile naming, residue identities, sequence, linkage notation, branches, and boundaries. Separate a native motif from any deliberate analog or derivatization.

2 Evaluate Route Feasibility

Review chemical, enzymatic, or combined approaches, including building-block availability, substrate specificity, protection logic, and sensitive terminal features.

3 Agree Comparators and Acceptance Evidence

Define the individual structures in a series and select methods for identity, relevant isomers, purity, and end-group confirmation. Set content or concentration reporting when needed.

4 Assemble, Deprotect, and Purify

Prepare the agreed structure and assess the final format. Evaluate partial extension, loss of sensitive groups, or other plausible alternatives as required by the project.

5 Deliver the Defined Glycan Package

Supply the agreed material with batch-linked analytical records and a clear structure identifier. Distinguish confirmed assignments from any explicitly stated analytical limitations.

Project advantages

How BOC Sciences Supports Defined Oligosaccharide Projects

The practical value of an oligosaccharide project comes from controlling the structural difference that the study is designed to investigate.

Complete Molecular Definition

Sequence, topology, terminal caps, and reducing-end chemistry stay linked throughout project review and documentation.

Route Selection by Structural Demand

Assembly options are evaluated for the actual linkage and substitution pattern, including difficult analogs and sensitive modifications.

Comparators Designed as a Series

Related targets can be planned around one deliberate change while retaining agreed common presentation features.

Analytical Scope Connected to the Hypothesis

The evidence package addresses relevant isomers and incomplete products rather than relying on mass or composition alone.

One connected glycan platform

Related Glycan Assembly and Probe Services

Related insights

Oligosaccharide Synthesis Resources

Explore supporting information on structure definition, synthesis, and purification for your glycan research project.

Step-by-Step Overview of the Glycan Synthesis ProcessChallenges and Solutions in Complex Glycan SynthesisWhat Is Glycan Synthesis? A Complete Beginner's Guide

Frequently asked questions

Oligosaccharide Synthesis FAQs

Answers to common questions about structural scope, analytical evidence, and custom synthesis requests.

What information defines a custom oligosaccharide?

Provide residue identities and order, linkage positions, anomeric configurations, branch topology, terminal modifications, and both end groups. A composition or a glycan family name does not uniquely define the requested molecule.

References

  1. Plante, Obadiah J., Emma R. Palmacci, and Peter H. Seeberger. Automated solid-phase synthesis of oligosaccharides. Science, 2001, 291(5508):1523-1527. DOI: 10.1126/science.1057324.
  2. Li, Tiehai, et al. An automated platform for the enzyme-mediated assembly of complex oligosaccharides. Nature Chemistry, 2019, 11(3):229-236. DOI: 10.1038/s41557-019-0219-8.
  3. Liu, Renpeng, et al. Chemoenzymatic design of heparan sulfate oligosaccharides. Journal of Biological Chemistry, 2010, 285(44):34240-34249. DOI: 10.1074/jbc.M110.159152.

Define the molecule your study needs

Define Your Custom Oligosaccharide Synthesis Project

Send the complete glycan sequence, desired presentation format, and the structural comparison your research needs. BOC Sciences can review route options, comparator design, and an analytical package matched to the requested oligosaccharide.

Contact BOC Sciences to discuss the target structure, proposed analytical package, and project-specific specifications. Services are intended for research use.

Request a Custom Quote
* Only for research. Not suitable for any diagnostic or therapeutic use.
Send Inquiry
Verification code